Delivery Order SPE2DB22D2206-SPE2DB24FJB30

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription medication Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The $11,727.62 firm fixed price contract was awarded on April 22, 2024 by the Defense Logistics Agency (DLA), with an ultimate completion date of April 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,773.64 and a completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,451.40 firm fixed price delivery order is for the provision of the prescription medication Trulicity 1.5 mg/0.5 ml pen, with a completion date of June 10, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,069 units of the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. The $3,893.17 fixed-price contract was awarded on July 3, 2024 by the Defense Logistics Agency (DLA), with a completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,334.75 and a completion date of July 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,451.40 firm-fixed-price delivery order has a completion date of June 25, 2024 and was awarded on June 24, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,905.48 firm fixed-price delivery order is for the supply of 4,565,007,428 units of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of the prescription medication Trulicity (1.5 mg/0.5 ml pen) to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,708.59 and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a $2,031.96 firm fixed-price delivery order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,161.12 Firm Fixed Price Delivery Order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJB30
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication Trulicity 1.5 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), is a $1,741.68 Firm Fixed Price delivery order with a completion date of July 8, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 10/4/24, 9:20 AM